VIDA FLaSH Acquisitions registered with the SEC to offer 17.5 million units at $10 each.
The new SPAC plans to target the healthcare sector in the United States.
VIDA is led by CEO and Director Dr. Frank Litvack, an interventional cardiologist and former co-director of the Cardiovascular Intervention Center at Cedars Sinai in Los Angeles and a Professor of Medicine at UCLA.
The SPAC intends to list on the Nasdaq under FLSHU. Read more.
